Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis

Early and differential diagnosis of intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC) by noninvasive methods represents a current clinical challenge. The analysis of low‐molecular‐weight metabolites by new high‐throughput techniques is a strategy for identifying biomarkers. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Banales, Jesus M., Iñarrairaegui, Mercedes, Arbelaiz, Ander, Milkiewicz, Piotr, Muntané, Jordi, Muñoz‐Bellvis, Luis, La Casta, Adelaida, Gonzalez, Luis M., Arretxe, Enara, Alonso, Cristina, Martínez‐Arranz, Ibon, Lapitz, Ainhoa, Santos‐Laso, Alvaro, Avila, Matias A., Martínez‐Chantar, Maria L., Bujanda, Luis, Marin, Jose J.G., Sangro, Bruno, Macias, Rocio I.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767196/
https://www.ncbi.nlm.nih.gov/pubmed/30325540
http://dx.doi.org/10.1002/hep.30319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767196/
https://www.ncbi.nlm.nih.gov/pubmed/30325540
http://dx.doi.org/10.1002/hep.30319

Ejemplares similares